Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), A. Mansur (Birmingham, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), L. Heaney (Oxford, United Kingdom), S. Fowler (Manchester, United Kingdom), P. Bradding (Leicester, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom)
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Couillard (Oxford, United Kingdom), R. Shrimanker (Oxford, United Kingdom), G. Hynes (Oxford, United Kingdom), C. Borg (Oxford, United Kingdom), C. Connolly (Oxford, United Kingdom), A. Hayman (Oxford, United Kingdom), S. Thulborn (Oxford, United Kingdom), A. Moran (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), T. Powell (Oxford, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), A. Mansur (Birmingham, United Kingdom), L. Mcgarvey (Belfast, United Kingdom), L. Heaney (Oxford, United Kingdom), S. Fowler (Manchester, United Kingdom), P. Bradding (Leicester, United Kingdom), I. Pavord (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom). Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway. 3111
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: